Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
2
users have commented on this narrative
19
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
4
users have commented on this narrative
16
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Marley Spoon Group
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Rising Costs And Competition Will Constrain Growth With Cautious Recovery
Key Takeaways Rising inflation, saturated competition, and cost-of-living concerns may limit revenue growth and squeeze margins despite improvements in order value and operational efficiency. Regulatory shifts and escalating sustainability demands could increase operating expenses, potentially offsetting gains from Marley Spoon's eco-friendly initiatives and supply chain optimizations.
View narrative
€1.30
FV
68.8% undervalued
intrinsic discount
-2.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Bionano Genomics
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Operating Losses Will Curb Genomics Progress Yet Kindle Modest Recovery
Key Takeaways Extended operating losses, slow clinical guideline adoption, and reimbursement uncertainty threaten liquidity, margin improvement, and revenue acceleration despite advancements in genomics technology. Competitive pressure, lagging research budgets, and slow global market integration may limit growth prospects even as software and consumables adoption rises.
View narrative
US$8.00
FV
59.1% undervalued
intrinsic discount
29.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Plus Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Advanced Radiotherapeutics Will Capitalize On Aging Cancer Demographics
Key Takeaways Streamlined operations, non-dilutive funding, and integrated diagnostics position the company for accelerated growth and competitive advantage in underserved CNS oncology markets. Strategic pipeline progress and unique manufacturing capabilities make Plus an attractive acquisition target, with strong potential for outsized long-term gains and market leadership.
View narrative
US$20.50
FV
97.4% undervalued
intrinsic discount
92.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Allurion Technologies
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Global Obesity Trends And Telemedicine Will Accelerate Non-invasive Weight Loss
Key Takeaways Combination therapy and pipeline innovation position the company to become the leading non-invasive obesity solution with resilient, high-margin recurring revenues. Accelerated regulatory milestones and expanding global reimbursement could rapidly scale adoption, revenue diversification, and earnings beyond initial expectations.
View narrative
US$16.00
FV
85.9% undervalued
intrinsic discount
-5.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Super League Enterprise
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Mobile Gaming, TikTok Ecosystem, And Esports Will Fuel Interactive Growth
Key Takeaways Strategic pivot to scalable mobile gaming, exclusive partnerships, and innovative ad formats is set to drive explosive growth, user engagement, and premium monetization opportunities. Expansion into data analytics, Web3 initiatives, and a larger salesforce positions the company for dominance in digital gaming, recurring high-margin revenue, and accelerated profitability.
View narrative
US$40.00
FV
91.6% undervalued
intrinsic discount
32.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Knightscope
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
New Facility And ASR Expansion Will Improve Production Efficiency
Key Takeaways Knightscope's revenue growth and focus on cost control indicate potential future profitability and expanded market reach. Operational efficiency improvements and automation strategies suggest Knightscope is positioned for sustained long-term earnings growth.
View narrative
US$19.00
FV
73.3% undervalued
intrinsic discount
24.80%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
Updated
narrative
Nextracker
AN
AnalystConsensusTarget
Consensus Narrative from 25 Analysts
Global R&D Expansion And Strong Solar Demand Will Strengthen Position, But Profit Margins May Decline
Key Takeaways Strategic R&D expansion and partnerships reinforce Nextracker's leadership in solar technology, positively impacting long-term revenue and growth. Strong demand and localized supply chain enhance competitive advantage, boosting U.S. market share and financial performance.
View narrative
US$70.68
FV
5.8% undervalued
intrinsic discount
11.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
44
users have followed this narrative
Updated
narrative
Tencent Music Entertainment Group
AN
AnalystConsensusTarget
Consensus Narrative from 31 Analysts
Rising Smartphone Usage And Fan Economy Will Transform Entertainment
Key Takeaways Innovative digital offerings, proprietary content, and technology investments are strengthening user engagement, operational efficiency, and competitive market position. Diversification into live events, merchandise, and enhanced fan interactions is broadening revenue streams and building greater brand resilience.
View narrative
US$28.14
FV
10.1% undervalued
intrinsic discount
14.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
21
users have followed this narrative
Updated
narrative
BlackRock
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Private Markets And Emerging Regions Will Strengthen Future Prospects
Key Takeaways Strategic acquisitions and emerging market expansion position BlackRock to benefit from rising demand for alternatives and global wealth growth. Technology integration and core product innovation support client retention, recurring revenues, and resilience against margin pressures.
View narrative
US$1.17k
FV
3.2% undervalued
intrinsic discount
10.45%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
81
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies